Cargando…
Report of chronic myeloid leukemia in chronic phase from All India Institute of Medical Sciences, 1990-2010
All India Institute of Medical Sciences is an Apex Institute and caters more than 1.5 million out-patients and 80,000 in-patients every year. In this study, they have presented interesting results of patients treated with interferon, interferon plus cytarabine and then with imatinib plus cytarabine....
Autores principales: | Mishra, Pravas, Seth, Tulika, Mahapatra, Manoranjan, Saxena, Renu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902613/ https://www.ncbi.nlm.nih.gov/pubmed/24516298 http://dx.doi.org/10.4103/0971-5851.123712 |
Ejemplares similares
-
Social and Financial Barriers to Optimum TKI Treatment in Patients with Chronic Myeloid Leukemia-A Knowledge-Attitudes-Practices Study from India
por: Gupta, Naveen, et al.
Publicado: (2021) -
Chronic myeloid leukemia with a rare fusion transcript, b2a3 (e13a3) BCR–ABL1: A report of four cases from India
por: Sazawal, Sudha, et al.
Publicado: (2019) -
Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019) -
Hairy cell leukemia: A decade long experience of North Indian Hematology Center
por: Somasundaram, Venkatesan, et al.
Publicado: (2014) -
Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
por: Chhikara, Sunita, et al.
Publicado: (2018)